Kwetaplex (Quetiapine)

Quetiapine works by blocking serotonin 5‑HT2A and dopamine D2 receptors, which helps rebalance neurotransmission involved in psychosis and mood regulation. Its additional antagonism at histamine H1, adrenergic α1, and other receptors contributes to sedation, blood‑pressure effects, and metabolic changes.

The appropriate dose of Kwetaplex is individualized by the prescribing clinician based on the patient’s diagnosis, severity, age, and response. Dosage titration follows clinical guidelines, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Kwetaplex is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It should be used during pregnancy only if the potential benefit justifies any possible risk. Breastfeeding is not recommended unless the benefit outweighs the potential exposure to the infant.

To order Kwetaplex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with first‑generation antipsychotics, quetiapine has a lower risk of extrapyramidal symptoms but a higher propensity for sedation, weight gain, and metabolic effects. Relative to other atypicals, its receptor profile offers strong antihistaminic activity, which can be advantageous for patients needing sleep support but may increase daytime drowsiness.

Kwetaplex tablets should be stored at ambient temperature, preferably below 25 °C, in their original container to protect from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Kwetaplex is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed. Dosing time (morning or evening) may be adjusted to minimise sedation.

Serious risks include neuroleptic malignant syndrome, severe hypotension, agranulocytosis, seizures, and suicidal thoughts, especially during early treatment or dose changes. Patients should seek immediate medical attention if they experience high fever, muscle rigidity, unexplained bruising, persistent dizziness, or new depressive thoughts.

Kwetaplex is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients. Caution is advised for patients with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome. It should not be used in children under the age approved for the specific indication without specialist guidance.